Diagnostic Imaging as a Foundation for Radioligand Therapy
Radioligand Therapy relies heavily on diagnostic imaging to guide treatment decisions. Molecular imaging techniques such as PET and SPECT scans are used to visualize receptor expression on tumors.
Before therapy begins, patients undergo imaging with diagnostic radioligands to confirm that their tumors express the target receptor. This ensures that Radioligand Therapy will be effective.
Imaging also helps assess disease distribution, treatment response, and progression. By tracking radioligand uptake over time, clinicians can adjust treatment strategies accordingly.
This integration of imaging and therapy allows for a highly personalized treatment approach and improves clinical outcomes.
1 View